Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.720
-0.050 (-1.81%)
At close: Mar 6, 2026, 4:00 PM EST
2.730
+0.010 (0.37%)
After-hours: Mar 6, 2026, 7:46 PM EST
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $640.37 million as of March 6, 2026. Its market cap has increased by 75.68% in one year.
Market Cap
640.37M
Enterprise Value
1.15B
1-Year Change
75.68%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $640.37M, an increase of 213.75%. That is a compound annual growth rate of 9.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 650.30M | -26.48% |
| Dec 31, 2025 | 884.50M | 104.04% |
| Dec 31, 2024 | 433.50M | 27.50% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cronos Group | 976.99M |
| Pacira BioSciences | 890.78M |
| Amphastar Pharmaceuticals | 877.46M |
| BioAge Labs | 847.16M |
| Tilray Brands | 840.01M |
| Ironwood Pharmaceuticals | 570.70M |
| Kamada | 523.39M |
| Aquestive Therapeutics | 515.03M |